New coaching program helps south asians lower blood sugar
NCT ID NCT03333044
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tested a program to help South Asian adults with uncontrolled diabetes. It combined group health coaching sessions led by community health workers with electronic alerts for doctors. Over 850 participants took part. The goal was to see if this approach could lead to a meaningful drop in blood sugar levels.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Community health worker-led health coaching and electronic health record alerts
- What this could lead to
- If successful, this approach could provide a practical, low-cost way to help South Asian patients better manage their diabetes and lower blood sugar levels.
- What could go wrong
- This is a completed study, but results may not apply to other populations or settings. The intervention is behavioral and depends on patient engagement, which can vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
One Park Avenue
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins